3,8,15,20,27,32,39,44-Octaoxapentacyclo[44.2.2.210,13.222,25.234,37]hexapentaconta-10,11,12,22,23,24,34,35,36,46,48,49-dodecaene-2,9,14,21,26,33,38,45-octone; 3,8,15,20,27,32,39,44-Octaoxapentacyclo[44.2.2.210,13.222,25.234,37]hexapentaconta-10,12,22,24,34,36,46,48,49,51,53,55-dodecaene-2,9,14,21,26,33,38,45-octone; Terephthalic acid, tetramol. cyclic tetramethylene ester; 1,4-Butanediol, tetramol. cyclic terephthalate;Cyclotetrakis(1,4-butylene Terephthalate)
Cyclotetrakis (1,4-butylene Terephthalate) is a fully characterized chemical compound used as a reference standard of API Pharacine. The standard offered is compliant with regulatory guidelines. Cyclotetrakis (1,4-butylene Terephthalate) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 29278-72-6
